- Home
- Standardized Extracts
- Notoginseng Extract
Notoginseng Extract (Panax notoginseng) – Ginsenoside Rb1 20–35%
Panax notoginseng
- Marker compound
- Ginsenoside Rb1
- Standardisation
- 20–35% (HPLC)
- Assay method
- HPLC
- Plant part
- Root
- Origin
- China
Notoginseng Extract (Panax notoginseng) – Ginsenoside Rb1 20–35%
Notoginseng extract is produced from the root of Panax notoginseng (Araliaceae family) and supplied as a standardized extract powder, standardized to Ginsenoside Rb1. Available grades: 20%, 35%. Typical sourcing: China. For B2B formulation in nutraceuticals & supplements.
20%35%
Specifications
| Botanical name | Panax notoginseng |
| Common names | Notoginseng, Sanqi |
| Plant family / part | Araliaceae / Root |
| Marker compound | Ginsenoside Rb1 |
| Phytochemical class | Terpenoids › Triterpenoids & triterpene saponins |
| Available grades | 20%, 35% |
| Assay method | HPLC |
| Pharmacopoeia & standards | Chinese Pharmacopoeia |
| Form | Standardized Extract |
| Origin | China |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Formulation focus
- Heart & Circulation
Industries
Nutraceuticals & Supplements
Traditional systems: Traditional Chinese Medicine
Documentation
The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Same product form